MELA Sciences Inc Share Price Nasdaq
Equities
US55277R3084
Advanced Medical Equipment & Technology
Sales 2024 * | 3.18Cr 265.27Cr | Sales 2025 * | 3.48Cr 290.17Cr | Capitalization | 1.47Cr 122.89Cr |
---|---|---|---|---|---|
Net income 2024 * | -70L -58Cr | Net income 2025 * | -50L -42Cr | EV / Sales 2024 * | 0.46 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.42 x |
P/E ratio 2024 * |
-2
x | P/E ratio 2025 * |
-2.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.41% |
Latest transcript on MELA Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10/18/10 |
Director of Finance/CFO | 42 | 06/21/06 | |
Shmuel Gov
COO | Chief Operating Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patricia Walker
BRD | Director/Board Member | 64 | 14/22/14 |
Uri Geiger
CHM | Chairman | 56 | 29/18/29 |
Homi Shamir
BRD | Director/Board Member | 70 | - |
1st Jan change | Capi. | |
---|---|---|
+12.85% | 23TCr | |
+13.88% | 20TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+1.67% | 6.49TCr | |
+18.24% | 5.43TCr | |
+7.04% | 5.21TCr | |
+10.83% | 4.52TCr | |
+5.94% | 3.74TCr |